🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSemaglutide and MASH — March 2026 Page 9

Semaglutide and MASH — March 2026

sophie_paris Tue, Dec 17, 2024 at 7:15 PM 42 replies 2,138 viewsPage 9 of 9
Dr.SurgeonPGH
Senior Member
1,345
6,789
Mar 2024
Pittsburgh, PA
Sep 19, 2025 at 12:08 PM#41
dan_philly said:
Keep the original post as written when you update it, and add the correction underneath.

This answered a question I did not know how to ask. I will report back once I have actually tried it.

40 13DoseLogDan, SleepFixSam, PurityPaulOR and 37 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Oct 1, 2025 at 1:38 PM#42

Adding the clinical framing, because it changes how the question reads. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

41 14roxy_nash, tony_orlando, Dr.NephBHM_UK and 38 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Oct 13, 2025 at 3:01 PM#43

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source. Carry on.

Last edited: Oct 13, 2025 at 7:01 PM
42 15RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 39 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
COA_Karl
Senior Member
2,123
8,901
Jan 2024
Pennsylvania
Oct 25, 2025 at 4:17 PM#44
roxy_nash said:
It helps to ask what evidence would change your mind before you look at any.

There is a second half to this that has not been said yet. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

43 16tommy_boulder, hyun_seoul, jim_asheville and 40 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Nov 6, 2025 at 5:26 PM#45

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

44 17Dr.GutHealth, amsterdam_pete, LondonLisa and 41 others
Reply Quote Save Share Report
1789

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register